- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.07. | Universal Ibogaine Inc: Universal Ibogaine CFO Leavens resigns | 9 | Stockwatch | ||
| 17.07. | Universal Ibogaine announces CFO departure | 13 | Seeking Alpha | ||
| 17.07. | Universal Ibogaine Inc.: Universal Ibogaine advises of departure of CFO | 3 | TheNewswire | ||
| 08.07. | Universal Ibogaine Inc: Universal Ibogaine director Cranwill resigns | 14 | Stockwatch | ||
| 08.07. | Universal Ibogaine Inc.: Universal Ibogaine Advises of Debt Settlement with CEO and Resignation of a Member of its Board of Directors | 5 | TheNewswire | ||
| 08.07. | Universal Ibogaine Inc: Universal Ibogaine 4,248,000 shares for debt | 2 | Stockwatch | ||
| 10.04. | XFRA JC4: WIEDERAUFNAHME/RESUMPTION | 239 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 08.04. | Universal Ibogaine Inc: Universal Ibogaine reinstated for trading | 9 | Stockwatch | ||
| UNIVERSAL IBOGAINE Aktie jetzt für 0€ handeln | |||||
| 04.04. | Universal Ibogaine Inc: Universal Ibogaine to issue 4.2 million shares for debt | 19 | Stockwatch | ||
| 03.04. | Universal Ibogaine Inc.: Universal Ibogaine Advises of Debt Settlement Agreement and Update on Status of Cease Trade Order | 16 | TheNewswire | ||
| 04.02. | XFRA JC4: AUSSETZUNG/SUSPENSION | 333 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILUNIVERSAL IBOGAINE... ► Artikel lesen |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SANOFI | 86,70 | +0,08 % | Sanofi SA-Aktie mit großen Kursgewinnen (86,7973 €) | Am Aktienmarkt brilliert zur Stunde das Wertpapier von Sanofi SA . Der Kurs des Papiers legt kräftig zu. Grund zur Freude haben Aktionäre von Sanofi SA: Die Aktie weist derzeit einen Wertanstieg von... ► Artikel lesen | |
| CANOPY GROWTH | 1,044 | -0,95 % | Canopy Growth Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
| ASTRAZENECA | 138,40 | +1,65 % | FibroGen, Inc.: FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation | Sale of FibroGen China remains on track to close in 3Q 2025 SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the China State Administration for Market... ► Artikel lesen | |
| INNOCAN PHARMA | 0,133 | +1,53 % | Innocan Pharma Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
| ROCKET LAB | 35,000 | 0,00 % | Rocket Lab Stock: Breakout Brewing or Time for Patience? | ||
| IONIS PHARMACEUTICALS | 36,570 | -0,49 % | Ionis Pharmaceuticals: Jefferies bestätigt Kaufempfehlung und Kursziel | ||
| HAPPY BELLY FOOD GROUP | 0,720 | +0,70 % | Happy Belly Food Group Inc.: Happy Belly Food Groups Heal Wellness QSR Announces the Signing of its Second Franchise Agreement for the Province of Quebec | Toronto, Ontario--(Newsfile Corp. - August 19, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands... ► Artikel lesen | |
| CSPC PHARMA | 1,110 | -6,29 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - DUPILUMAB INJECTION OBTAINS CLINICAL TRIAL APPROVAL IN CHINA | ||
| ALTIMMUNE | 3,115 | +0,42 % | Altimmune, Inc: Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD) | Pemvidutide is the only drug currently granted Fast Track Designation in AUD RECLAIM, a Phase 2 trial of pemvidutide in AUD, is currently enrolling GAITHERSBURG, Md., Aug. 19, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 17,540 | +0,52 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors | CORAL GABLES, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the appointment of Daniel Curran, MD, to its Board of... ► Artikel lesen | |
| AVADEL PHARMACEUTICALS | 11,800 | -4,06 % | Avadel Pharmaceuticals übertrifft im 2. Quartal 2025 die Erwartungen und erzielt erstmals Gewinn | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc. Announces Second Quarter Fiscal 2025 Results | Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company"), a mental health care company focused on... ► Artikel lesen | |
| ELANCO ANIMAL HEALTH | 15,150 | +1,13 % | Elanco CEO Jeff Simmons: Innovation and Sustainability Drive Long-Term Growth | NORTHAMPTON, MA / ACCESS Newswire / August 15, 2025 / Jeff Simmons, President and CEO of Elanco Animal Health, recently joined the Bloomberg Businessweek Daily to discuss the company's strategic framework... ► Artikel lesen | |
| ONO PHARMACEUTICAL | 9,700 | +0,52 % | Ono Pharmaceutical Co. Ltd. Reports Retreat In Q1 Bottom Line | WASHINGTON (dpa-AFX) - Ono Pharmaceutical Co. Ltd. (OPHLF.PK) revealed earnings for first quarter that Drops, from the same period last yearThe company's earnings totaled JPY17.673 billion,... ► Artikel lesen | |
| IANTHUS CAPITAL | 0,001 | 0,00 % | iAnthus Capital Holdings, Inc.: iAnthus Reports Second Quarter 2025 Financial Results | NEW YORK and TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis... ► Artikel lesen |
UNIVERSAL IBOGAINE INC gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 0,004 Euro und damit -42,86 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu UNIVERSAL IBOGAINE INC finden Sie auf Wallstreet Online.